Companies such as Integrated DNA Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Twist Bioscience (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), are major players in oligonucleotide synthesis market.
In December 2024, Co-Diagnostics, Inc. and its Indian joint venture, CoSara Diagnostics Pvt. Ltd., inaugurated CoSara's oligonucleotide synthesis facility in Ranoli, India. This new facility is designed to support the "Make in India" initiative by manufacturing the company's patented Co-Primers chemistry, which underpins Co-Dx's and CoSara's lab-based PCR diagnostic tests. In November 2023, Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, launched Twist Express Genes. This new gene synthesis service boasts a rapid order-to-shipping turnaround time of five to seven business days, significantly accelerating research and development workflows in gene editing, drug discovery, and other genomic applications
The countries covered in the oligonucleotide Synthesis market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.